Moreover, the Finnish section of ERSPC indicated that at least three rounds of PSA screening were needed to reduce subsequent PCa incidence and mortality [8, 9], which indicated multi-round PSA tests are necessary to enhance the effectiveness of screening for prostate cancer. The gene discussed is KLK3; the disease is posterior cortical atrophy.